Skip to content

Impact of a Transitional Care Program on 30-Day Hospital Readmissions for Elderly Patients Discharged From a Short Stay Geriatric Ward

Impact of a Transitional Care Program Involving an Advanced Practice Nurse on 30-Day Hospital Readmissions for Elderly Patients Discharged From a Short Stay Geriatric Ward (PROUST Study)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02421133
Acronym
PROUST
Enrollment
630
Registered
2015-04-20
Start date
2015-07-31
Completion date
2016-11-30
Last updated
2025-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Geriatrics

Keywords

Care transition program, Patient readmission, Transition Nurse, Stepped wedge, elderly

Brief summary

In France, it has be estimated that the hospital readmission rate within 30 days of patients aged 75 or older is 14% (IC95% \[12.0-16.7\]), nearly a quarter being avoidable. There is evidence that interventions bridging the transition from hospital to home involving a dedicated professional (usually nurses) would be most effective in reducing the risk of readmission, but the level of evidence of current studies is low. Our study aims to assess the impact of a program of transitional care from hospital to home for people of 75 years old or more admitted to acute care.

Detailed description

The study is a stepped wedge randomized cluster study. Intervention: The transition care program, involving a dedicated advanced practice nurse, will include: 1) during the patient's stay in hospital: an individualized needs-based comprehensive discharge plan and a transitional care record ; the notification of the primary care physician about inpatient care and hospital discharge; 2) the day of the discharge: specific explanations about the organization of home care provided by the transition care nurse to the patient; 3) during 4 weeks after discharge: monitoring patients and caregivers regularly through home visits and/or telephone contact,

Interventions

OTHERTransitional care program.

During the patient's stay in hospital, the transition nurse creates a transitional care file including information about the patient (inpatient medical and nurse care plan, medications), the discharge plan, and the contact information of the relevant primary care providers. She notifies the patient's primary care physician of the date of the discharge to home, of the potential medical problems and of the discharge care plan; a primary care physician visit is planned the month following the discharge. The day of the hospital discharge: meeting with the patient to review the follow-up recommendations. The transition nurse verifies that the medications are prescribed accordingly with the discharge plan, that the patient and his caregiver understand the prescription and are informed with the planned appointments and the biological monitoring. During 4 weeks after the hospital discharge: follow-up by the transition nurse once a week, alternately by telephone and home visit.

The patients will be discharged according to the usual care plan of each participating hospital. The medical team does a medical and geriatric assessment of the patients according to the recommendations. The communication of information to the primary care providers (nurse, primary care physician…) is left to the discretion of the medical teams of the discharging hospitals, according to their habits of work.

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
75 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient hospitalized for 48 hours or more in one of the acute geriatric service participating to the study. * Aged 75 or older. * Leaving at home and with home as the planned discharge after the admission. * At risk of hospital readmission emergency visit rates after discharge (if he has two or more of the following criteria (taken from the Triage Risk Screening Tool and from the 2013 French recommendation)).

Exclusion criteria

* Patient leaving in a retirement home. * Patient hospitalized at home. * Patient leaving at home but at 30 km (18 miles) or more from the service of his index admission

Design outcomes

Primary

MeasureTime frameDescription
30-Day unscheduled hospital readmission or emergency visit rate after the index hospital discharge.Within 30 days after hospital discharge.Unscheduled hospital readmissions are hospitalizations that are not planned at the moment of the discharge (for example: hospitalization after an emergency visit or upon request of the primary care physician).

Secondary

MeasureTime frameDescription
Unscheduled hospital readmissions or emergency room visitsWithin 30 and 90 days after the index hospital discharge.
Free-hospitalization survivalWithin 30 and 90 days after the index hospital discharge.
Mortality rateWithin 30 and 90 days after the index hospital discharge.
Adverse events (i.e. falls)Within 30 days after the index hospital discharge.
Length of stay in the short stay geriatric ward (index hospitalization)Patients will be followed for the duration of hospital stay, an expected average between 2 days and 30 days
Patients' satisfaction care transition programmeWithin 30 days after the index hospital discharge.Measured with the Care Transition Measure® questionnaire.
Delay between the index hospital discharge and the implementation of home care.Within 30 days after the index hospital discharge.
Number of contacts between the transition nurse and the primary care providers or the hospital providers after dischargeWithin 30 days after the index hospital discharge.
Costs of unscheduled hospital readmission or emergency visit30 days after dischargeHospital and community care costs after discharge
Quality of life.Within 30 days after the index hospital discharge.Measured with the French version of the EUROQOL-5D.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026